PROFITABLE | FAST GROWING | PHARMA COMPANY
MEETING THE GAPS IN CRITICAL CARE
Delex Healthcare Group Inc. (DELEX) was incorporated in 2017 in Delaware, USA. DELEX is engaged in the development and distribution of pharmaceutical and healthcare products through its subsidiaries, Delex Pharma International Inc. (Delex Pharma), DLX Holdings, Corp., and JMN Brother’s Pharma Limited, Inc.
DELEX Pharma International, Inc. (Delex Pharma) was incorporated in 2010 in Manila, Philippines. Delex Pharma currently has over 100 sales and marketing teams and over 1,000 distribution channels including hospitals, pharmacies, and healthcare centers across the country.
DELEX aims to close the gaps that patients experience in coping with the many difficulties in the ICU (Intensive Care Units) with alternative drugs that can meet those needs. In so doing, we stay true to our commitment of “meeting the gaps in critical care”
AWARDS & RECOGNITIONS
Why Choose Us
STRONG MARKET & GROWTH POTENTIAL
OVER 10 YEARS
OF BUSINESS OPERATION
OWN PRODUCTS
FOR GLOBAL MARKETS
OVER 1,000
DISTRIBUTION CHANNELS
FDA LICENSES
PROVEN QUALITY & COMPLIANCE
EXPANSION
LEAR EXPANSION PLANS
$1.5 TRILLION
GLOBAL PHARMA MARKET